The International Longevity Alliance (ILA) has announced the inclusion of Transhumanists Africa as its latest federated member. This collaboration aims to further the cause of healthy longevity through scientific research across Africa and globally. Transhumanists Africa operates in Nigeria, Ethiopia, Ivory Coast, and Botswana, promoting longevity technologies in these regions.
This membership follows the recent additions of Blanc Alliance Public Affairs from Romania in January 2024, the Aeon Foundation from Italy in February 2024, and the Science for Life Extension Foundation from Russia in the same month. The Aeon Foundation focuses on translating scientific research into life-extending policies through interdisciplinary collaborations. The Science for Life Extension Foundation is dedicated to combating aging and death, akin to past victories over diseases like typhus and smallpox.
Last month, the Vitalism Foundation, a Delaware-based non-profit advocating for longevity, also joined ILA. The Vitalism movement calls for the creation of Longevity States, rallying longevity maximalists to unify against aging and death.
Additionally, the Longevity Alliance Baltic has expanded to include branches in Finland and Poland, alongside its original branches in Latvia, Lithuania, and Estonia. The European Society of Preventive, Regenerative and Anti-Aging Medicine (ESAAM) has relocated its incorporation from Austria to Switzerland, now encompassing branches in several countries including Germany, Cyprus, and Malaysia. The Israeli Longevity Alliance has fully merged with Vetek (Seniority) Association – The Movement for Longevity and Quality of Life (Israel).
These updates bring the total number of ILA federated organizations to 56, spanning 45 countries, with 33 countries of incorporation and 12 country branches.
ILA aims to create a world where innovative medical technologies enable aging amelioration and healthy longevity for all. Established in 2012 and registered as a foundation in France in 2014, ILA continues to promote longevity through scientific research, new drug development, public health policy improvements, and education.
